Back to resultsTime to Perform Lung Function Test in Cystic Fibrosis
Primary Purpose
Cystic Fibrosis
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Lung function test
Sponsored by
About this trial
This is an interventional treatment trial for Cystic Fibrosis focused on measuring Lung function, Physiotherapy
Eligibility Criteria
Inclusion Criteria:
- Patients with cystic fibrosis
Exclusion Criteria:
- patients with cystic fibrosis who could not stay at the clinic for more than 4 hrs.
Sites / Locations
- Karolinska University Hospital
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Lung function test
Arm Description
Lung function test
Outcomes
Primary Outcome Measures
Lung function test. FEV1 and FVC
Secondary Outcome Measures
Full Information
NCT ID
NCT01737801
First Posted
November 19, 2012
Last Updated
November 29, 2012
Sponsor
Karolinska University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT01737801
Brief Title
Time to Perform Lung Function Test in Cystic Fibrosis
Official Title
Time to Perform Lung Function Test in Cystic Fibrosis After Chest Physiotherapy.
Study Type
Interventional
2. Study Status
Record Verification Date
November 2012
Overall Recruitment Status
Completed
Study Start Date
February 2008 (undefined)
Primary Completion Date
January 2012 (Actual)
Study Completion Date
September 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska University Hospital
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Time to perform lung function test after chest physiotherapy in cystic fibrosis.
The investigators study FEV1(forced expiratory volume in one second) and FVC (forced vital capacity).
Detailed Description
The patients perform spirometry before, direct after, 30 minutes, 1 hour, 2 hours, and 3 hours after physiotherapist. The investigators want to study the FEV1 and FVC.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
Keywords
Lung function, Physiotherapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
24 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Lung function test
Arm Type
Experimental
Arm Description
Lung function test
Intervention Type
Procedure
Intervention Name(s)
Lung function test
Other Intervention Name(s)
Lung function test.
Intervention Description
Lung function test.
Primary Outcome Measure Information:
Title
Lung function test. FEV1 and FVC
Time Frame
2 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with cystic fibrosis
Exclusion Criteria:
patients with cystic fibrosis who could not stay at the clinic for more than 4 hrs.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Cecilia Rodriguez, Physio
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Karolinska University Hospital
City
Stockholm
Country
Sweden
12. IPD Sharing Statement
Learn more about this trial
Time to Perform Lung Function Test in Cystic Fibrosis
We'll reach out to this number within 24 hrs